Clinical utility of survivin (BIRC5), novel cardiac biomarker, as a prognostic tool compared to high-sensitivity C-reactive protein, heart-type fatty acid binding protein and revised Lee score in elderly patients scheduled for major non-cardiac surgery: A prospective pilot study

Clinical utility of survivin (BIRC5), novel cardiac biomarker, as a prognostic tool compared to high-sensitivity C-reactive protein, heart-type fatty acid binding protein and revised Lee score in elderly patients scheduled for major non-cardiac surgery: A prospective pilot study

Background: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Full description

Bibliographic Details
Main Authors: Marković Danica, Jevtović-Stoimenov Tatjana, Ćosić Vladan S., Stošić Biljana, Dinić Vesna, Marković-Živković Bojana, Janković Radmilo J.
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2018-01-01
Series:Journal of Medical Biochemistry
Subjects:
survivin
cardiac morbidity: pre-operative factors
sensitivity
specificity
peri-operative risk of mi
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2018/1452-82581802110M.pdf

Internet

https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2018/1452-82581802110M.pdf

Similar Items